Diverging pathways

Genetic differences in tumors could shed light on disparity in clinical outcomes

Results from a National Cancer Institute study could explain disparities in treatment outcomes for African-Americans, who have the highest lung cancer incidence and mortality rates of any racial group.

The study, published in Clinical Cancer Research in December identified differences in mRNA expression and miRNA expression between lung tumors from African-Americans and European Americans.

“Race and ethnicity is just one factor in precision medicine, but it is important,” study

Read the full 678 word article

User Sign In